Why Covid-19 demands a change in approach to disease with Johnson and Johnson's Global Head, External Innovation

- Online Zoom Conference

Date

at
Location

Online Zoom Conference

About

Please join YJP and William N. Hait, M.D., Ph.D. Global Head, Johnson & Johnson External Innovation on February 8th, 2021 at 1 PM ET to discuss why Covid-19 demands a change in approach to disease

Dr. William N. Hait leads the external sourcing and creation of transformational innovation to help Johnson & Johnson achieve its mission to change the trajectory of health for humanity. He works on building an enterprise-wide external R&D pipeline, creating innovative solutions that utilize J&J’s excellence in pharmaceuticals, medical devices and consumer products. His team strives to identify disruptive technologies and cutting-edge early innovations in disease areas of emphasis at J&J, to eliminate disease through prevention, interception and cures. 

Through this mentorship initiative, young professionals will have the opportunity to explore innovative strategies to set your career goals for 2021. Our virtual community will have the opportunity to partake in an intimate and candid discussion with a Q&A session.

For questions about the event: please email erica@yjpnewyork.com

*YJP has a non-solicitation policy covering all of our conferences and events. In order to provide a distraction-free environment for our mentors, sponsors, attendees, and employees, we do not allow solicitation at our events by attendees or unauthorized parties without the express written permission or consent from YJP. 

D6d0bee85f0262a25305e234895d89276239365b large
Speaker
William N. Hait, M.D., Ph.D.
Global Head, Johnson & Johnson External Innovation at Johnson & Johnson

Dr. William N. Hait leads the external sourcing and creation of transformational innovation to help Johnson & Johnson achieve its mission to change the trajectory of health for humanity. He works on building an enterprise-wide external R&D pipeline, creating innovative solutions that utilize J&J’s excellence in pharmaceuticals, medical devices and consumer products. His team strives to identify disruptive technologies and cutting-edge early innovations in disease areas of emphasis at J&J, to eliminate disease through prevention, interception and cures.

9611d4abcc1bc42ed6191cb22793c9c1f1eddbc8 large
Moderator
Byron S. Kalogerou
Founder of the Firm’s Life Science Industry Group and Senior Partner at McDermott Will & Emery LLP

Byron S. Kalogerou is the founder of the Firm’s Life Science Industry Group and is the senior partner in the Boston Corporate Practice. He focuses his practice on domestic and cross-border mergers and acquisitions, finance, and joint ventures and alliances. He has substantial on-the-ground experience structuring mergers, acquisitions, divestitures and joint ventures on six continents. Byron has extensive industry background in the life science, industrial and manufacturing sectors. He also acts as outside general counsel to a number of companies.

Partial Guest List

37144d6d3542473ffc32e6cd34c4c551de3afd54 thumb
Users photos missing
969de8cbbbc6990aa76e0d19d96f99710d47f24c thumb
96cdb8586c07fed27f375593d48b3dc2aae39838 thumb
2151a9866cfe740bca00be64d38d19c209cacc33 thumb
Users photos missing
Ef956da5421aea56602e693117dc7be6e6dd603c thumb
Users photos missing
Users photos missing
F6a431eaf5d19e5a92bd840c5279a334a79a1809 thumb
Users photos missing
Ca49289967412fbf4ccf53dd6df14689eb3802e1 thumb
Db7e5f246e3aa5837c6911b47e9f6bb74d4ebff4 thumb
5e2f597c9ebc8a06f7ac90921dd90cb6c86480f9 thumb
E291fe21950c6adb797413dba7af5ff91a0e4dfb thumb
B5a9d810d3b36334f69be2c88c2cc6e9a249c069 thumb
Dc91ff123e49e27c0d0398e0054f0fa23b4cf81c thumb
Users photos missing
C3d115da19c50d6b9f04d8122e45ac62b9d5bec9 thumb
19cebee0cf1102819a44bc1e59968c5b9952ea32 thumb
E795b7862582ef2829714689bdff65824e4f0987 thumb
181ef769f497a7a3e86315778dc0a23c68d3a0e1 thumb
Event Over
This event has concluded.